Immunic Inc (IMUX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -50,964 | -29,584 | -93,612 | -72,040 | -49,271 |
| Depreciation Amortization | 57 | 26 | 111 | 88 | 54 |
| Accounts payable and accrued liabilities | 2,977 | 1,794 | 817 | -951 | 449 |
| Other Working Capital | -1,414 | -4,165 | 15,048 | 8,975 | 5,286 |
| Other Operating Activity | 8,336 | 7,960 | 6,808 | 7,127 | 3,993 |
| Operating Cash Flow | $-41,008 | $-23,969 | $-70,828 | $-56,801 | $-39,489 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | 9,796 | 9,796 | 9,796 |
| PPE Investments | -211 | -31 | -334 | -169 | -125 |
| Investing Cash Flow | $-211 | $-31 | $9,462 | $9,627 | $9,671 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 191 | 191 | 1,033 | 429 | 51 |
| Other Financing Activity | 74,273 | 74,273 | 0 | 0 | 96 |
| Financing Cash Flow | $74,464 | $74,464 | $1,033 | $429 | $147 |
| Exchange Rate Effect | -221 | 174 | 262 | -311 | 220 |
| Beginning Cash Position | 46,674 | 46,674 | 106,745 | 106,745 | 106,745 |
| End Cash Position | 79,698 | 97,312 | 46,674 | 59,689 | 77,294 |
| Net Cash Flow | $33,024 | $50,638 | $-60,071 | $-47,056 | $-29,451 |
| Free Cash Flow | |||||
| Operating Cash Flow | -41,008 | -23,969 | -70,828 | -56,801 | -39,489 |
| Capital Expenditure | -211 | -31 | -334 | -169 | -125 |
| Free Cash Flow | -41,219 | -24,000 | -71,162 | -56,970 | -39,614 |